Back to search

University of Ioannina

Σύγκριση νεώτερων συνθετικών αναστολέων της συσσώρευσης των αιμοπεταλίων με κλασσικούς αναστολείς της έκφρασης των γλυκοπρωτεϊνικών υποδοχέων IIb/IIIa: Πειραματική μελέτη

Abstract

dc:description

Inhibition of platelet aggregation is indispensable for the treatment of acute arterial thrombotic episodes. We have previously reported thesynthesis of a highly constrained cyclic peptide, that incorporates the -CDC- sequence, the (S,S)PSRCDCR-NH2, that potently inhibitsaggregation and fibrinogen binding to human platelets in vitro. We have tested the peptide’s safety and efficacy on the electrically inducedcarotid artery thrombosis experimental rabbit model. The peptide’s effects on carotid blood flow, thrombus weight, in vitro and ex vivo platelet aggregation and bleeding and haemostatic parameters were evaluated. The peptide was administered via the femoral vein. Carotidblood flow was continuously monitored for 90 min after electrical thrombus formation. The animals were divided in groups receivingintravenously a. Normal saline, 6 ml/kg/h (control group), b. the (S,S) PSRCDCR-NH2 to doses of 3,6 and 12 mg/kg, c. Heparin 100 IU/kg/h and d.eptifibatide in two different doses: 180 μg/kg bolus plus 2 μg/kg/min (low dose) and 900 μg/kg bolus plus 10 μg/kg/min (high dose). Carotid artery thrombus formation (under continuous blood flow monitoring) was induced by electrical stimulation. Ex vivo platelet aggregation to 20 ADP and ΑΑ in platelet rich plasma (PRP) levels) were determined before (baseline) and at 60 min after the initiation of drug administration (instantly prior to electrical stimulation). Ninety minutes after electrical stimulation the carotid thrombus was removed and weighed. Blood loss was calculated by the amount of blood, gathered on a pre-weighed gauge, positioned on a standardized incision, performed on the anterior abdominal wall. In the control group, carotid artery was totally occluded within 23.3±3.2 min after electrical stimulation. By contrast, in the (S,S)PSRCDCR-NH2 (6 and 12 mg), heparin and eptifibatide groups, carotid artery blood flow at 90 min after electrical stimulation, was reduced to 32±0,01%, 46.3±0.01% 26,3%±12,7%, 36,9±5,0% (low dose), 35,3±5,1% (high), respectively (p<0,001 over control). Similarly, thrombus weight was significantly reduced in animals receiving (S,S) PSRCDCR-NH2 (6 and mg/kg), heparin or eptifibatide over control: 2.95±0.2mg, 2.13±0.08, 3,92±0,74mg and 1,72±0,58 mg (low dose) and 2,1±1,1 mg (high dose) over 5,72±0,86mg respectively, p<0,01). Platelet maximum aggregation to ADP and AA in the control group, 60 min after electrical stimulation, was not altered compared to baseline, whereas it was significantly reduced by 42±3%, 28,0±6,6%(low dose),38,3±11,0% (high dose) in the (S,S) PSRCDCR-NH2 (12 mg/ kg) and eptifibatide groups respectively, (p<0.004). There were no significantvariations regarding blood loss and bleeding times in the eptifibatide and the (S,S)PSRCDCR-NH2 groups compared to control group The peptide, at 12 mg/kg, prevented total artery occlusion and significantly preserved carotid artery’s patency compared with placebo and eptifibatide. Furthermore, (S,S) PSRCDCR-NH2 administration at 12 mg/kg reduced thrombus weight, whereas it inhibited ex vivo ADP, arachidonic acid (AA) Moreover the (S,S) PSRCDCR-NH2 at 12 mg/kg presented significantly higher inhibitory effects on AA ex vivo platelet aggregation compared to eptifibatide. The peptide at any dose, did not affect the bleeding times and the haemostatic response of the animals. Thus highly constrained cyclic peptides like (S,S) PSRCDCR-NH2 that incorporate the -CDC- motif and fulfil certain conformational criteria represent novel compounds that potently inhibit thrombus formation, ex vivo platelet aggregation and carotid artery occlusion superiorly to other non-RGD peptides without causing haemorrhagic complications in a rabbit model of arterial thrombosis.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Roussa, Vassiliki
  • Ρούσσα, Βασιλική

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27641

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Roussa, Vassiliki; Ρούσσα, Βασιλική. Σύγκριση νεώτερων συνθετικών αναστολέων της συσσώρευσης των αιμοπεταλίων με κλασσικούς αναστολείς της έκφρασης των γλυκοπρωτεϊνικών υποδοχέων IIb/IIIa: Πειραματική μελέτη. University of Ioannina, 2011. http://hdl.handle.net/10442/hedi/27641